Photochemotherapy for Psoriasis
- 1 December 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 113 (12) , 1667-1670
- https://doi.org/10.1001/archderm.1977.01640120035003
Abstract
• Photochemotherapy for psoriasis combining orally administered methoxsalen and long-wave ultraviolet (UVA) light was used in 186 patients with severe psoriasis. Several different phototherapy units with various numbers of GE high-output black lights were used. Excellent (90% to 100% clear) and good (80% to 90% clear) results were obtained in 77% of the patients. The average UVA dose at clearing was between 7 and 8 joules/sq cm. The majority of patients required one weekly maintenance UVA dose of their last clearing dose (joules per square centimeter) to remain clear. Side effects and abnormal laboratory findings were minimal. (Arch Dermatol 113:1667-1670, 1977)This publication has 7 references indexed in Scilit:
- Cataract Induction in Mice Exposed to Near UV LightOphthalmic Research, 1974
- Resistant psoriasis. Combined methoxsalen-anthralin therapyArchives of Dermatology, 1973
- Methotrexate. Mechanism of action on DNA synthesis in psoriasisArchives of Dermatology, 1971
- Abnormal Cell Proliferation in Psoriasis**From the Department of Dermatology, University of Miami School of Medicine, Miami, Florida.Journal of Investigative Dermatology, 1968
- Part IV: Basic Considerations of the Psoralens: Clinical and Laboratory Tolerance Studies in Volunteers Given Oral MethoxsalenJournal of Investigative Dermatology, 1959
- EFFECT OF METHOXSALEN ON LIVER FUNCTIONJAMA, 1958
- Clinical and Experimental Studies with 8-Methoxypsoralen in Vitiligo1Journal of Investigative Dermatology, 1953